Erlotinib therapy after initial platinum doublet therapy in patients with EGFR wild type non-small cell lung cancer: results of a combined patient-level analysis of the NCIC CTG BR...

Por Osarogiagbon, Raymond U., Cappuzzo, Federico, Ciuleanu, Tudor, Leon, Larry, Klughammer, Barbara
Publicado no Transl Lung Cancer Res (2015)

Gefitinib Treatment in EGFR Mutated Caucasian NSCLC: Circulating-Free Tumor DNA as a Surrogate for Determination of EGFR Status

Por Douillard, Jean-Yves, Ostoros, Gyula, Cobo, Manuel, Ciuleanu, Tudor, Cole, Rebecca, McWalter, Gael, Walker, Jill, Dearden, Simon, Webster, Alan, Milenkova, Tsveta, McCormack, Rose
Publicado no J Thorac Oncol (2014)

A phase II study to evaluate LY2603618 in combination with gemcitabine in pancreatic cancer patients

Por Laquente, Berta, Lopez-Martin, Jose, Richards, Donald, Illerhaus, Gerald, Chang, David Z., Kim, George, Stella, Philip, Richel, Dirk, Szcylik, Cezary, Cascinu, Stefano, Frassineti, G. L., Ciuleanu, Tudor, Hurt, Karla, Hynes, Scott, Lin, Ji, Lin, Aimee Bence, Von Hoff, Daniel, Calvo, Emiliano
Publicado no BMC Cancer (2017)

Cetuximab plus FOLFOX6 or FOLFIRI in metastatic colorectal cancer: CECOG trial

Por Ocvirk, Janja, Brodowicz, Thomas, Wrba, Fritz, Ciuleanu, Tudor E, Kurteva, Galina, Beslija, Semir, Koza, Ivan, Pápai, Zsuzsanna, Messinger, Diethelm, Yilmaz, Ugur, Faluhelyi, Zsolt, Yalcin, Suayib, Papamichael, Demetris, Wenczl, Miklós, Mrsic-Krmpotic, Zrinka, Shacham-Shmueli, Einat, Vrbanec, Damir, Esser, Regina, Scheithauer, Werner, Zielinski, Christoph C
Publicado em 2010

The trifunctional antibody catumaxomab for the treatment of malignant ascites due to epithelial cancer: Results of a prospective randomized phase II/III trial

Por Heiss, Markus M, Murawa, Pawel, Koralewski, Piotr, Kutarska, Elzbieta, Kolesnik, Olena O, Ivanchenko, Vladimir V, Dudnichenko, Alexander S, Aleknaviciene, Birute, Razbadauskas, Arturas, Gore, Martin, Ganea-Motan, Elena, Ciuleanu, Tudor, Wimberger, Pauline, Schmittel, Alexander, Schmalfeldt, Barbara, Burges, Alexander, Bokemeyer, Carsten, Lindhofer, Horst, Lahr, Angelika, Parsons, Simon L
Publicado em 2010

Ipilimumab versus placebo after radiotherapy in patients with metastatic castration-resistant prostate cancer that had progressed after docetaxel chemotherapy (CA184-043): a multic...

Por Kwon, Eugene D, Drake, Charles G, Scher, Howard I, Fizazi, Karim, Bossi, Alberto, van den Eertwegh, Alfons J M, Krainer, Michael, Houede, Nadine, Santos, Ricardo, Mahammedi, Hakim, Ng, Siobhan, Maio, Michele, Franke, Fabio A, Sundar, Santhanam, Agarwal, Neeraj, Bergman, Andries M, Ciuleanu, Tudor E, Korbenfeld, Ernesto, Sengeløv, Lisa, Hansen, Steinbjorn, Logothetis, Christopher, Beer, Tomasz M, McHenry, M Brent, Gagnier, Paul, Liu, David, Gerritsen, Winald R
Publicado no Lancet Oncol (2014)